Latest News

Senators blast Novartis over data manipulation before approval of Zolgensma

WASHINGTON — A group of senators, including presidential hopefuls Sens. Elizabeth Warren (D-Mass.) and Bernie Sanders (I-Vt.), blasted Novartis on Friday for failing to promptly disclose that falsified data were used to win approval for the company’s $2.1 million gene therapy, Zolgensma.

The Food and Drug Administration earlier this week said AveXis, a subsidiary of Novartis, was aware of “data manipulation” involving Zolgensma, which was approved in May to treat spinal muscular atrophy, but failed to disclose it to the agency until months later.

Read the rest…

Source link

Related posts

Women with independent living challenges have highest risk for unintended pregnancy


How Einstein Medical Center is using remote monitoring tech to decrease readmissions


Questions to ask before a surgical procedure


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World